APEPTICO's core competency centers around peptides – short chains of amino acids – and their application in medicine. This suggests involvement in various areas including:

• Peptide Drug Development: Research and development of novel peptide-based drugs for therapeutic purposes. This could involve developing drugs for various diseases or conditions, leveraging peptides' advantages such as high specificity and low toxicity compared to other therapeutic classes.
• Peptide Diagnostics: Designing and developing peptide-based diagnostic tools. This might involve developing diagnostic tests for specific diseases or biomarkers, potentially facilitating early disease detection or personalized medicine approaches.
• Contract Research and Development (CRD): APEPTICO might provide services to other companies in the biotech industry, offering their expertise in peptide chemistry and drug development to aid in the development of their products. This is a common practice for smaller biotech firms.
• Custom Peptide Synthesis: The company could potentially offer custom synthesis of peptides to researchers or other companies requiring specific peptide sequences for their research or development work.

Geographic Location:

While the website doesn't explicitly state their location, it is implied to be Austria, based on the company name (GmbH is a German designation) and the website's likely origin.

Overall Assessment:

APEPTICO Forschung und Entwicklung GmbH appears to be a specialized biotech company operating within a niche but promising area of life sciences. Their focus on peptides suggests a dedication to developing innovative solutions with potentially significant impact on healthcare and diagnostics. Further information about their specific research projects, collaborations, and financial standing would require direct contact with the company.